These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30806304)

  • 21. Biosensors Integration in Blood-Brain Barrier-on-a-Chip: Emerging Platform for Monitoring Neurodegenerative Diseases.
    Mir M; Palma-Florez S; Lagunas A; López-Martínez MJ; Samitier J
    ACS Sens; 2022 May; 7(5):1237-1247. PubMed ID: 35559649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung on a Chip for Drug Screening and Design.
    Kızılkurtlu AA; Polat T; Aydın GB; Akpek A
    Curr Pharm Des; 2018; 24(45):5386-5396. PubMed ID: 30734673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organ-on-chip models: Implications in drug discovery and clinical applications.
    Mittal R; Woo FW; Castro CS; Cohen MA; Karanxha J; Mittal J; Chhibber T; Jhaveri VM
    J Cell Physiol; 2019 Jun; 234(6):8352-8380. PubMed ID: 30443904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What human blood-brain barrier models can tell us about BBB function and drug discovery?
    Ferreira L
    Expert Opin Drug Discov; 2019 Nov; 14(11):1113-1123. PubMed ID: 31385723
    [No Abstract]   [Full Text] [Related]  

  • 26. Laser printing-enabled direct creation of cellular heterogeneity in lab-on-a-chip devices.
    Xiong R; Chai W; Huang Y
    Lab Chip; 2019 Apr; 19(9):1644-1656. PubMed ID: 30924821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood brain barrier: A tissue engineered microfluidic chip.
    Musafargani S; Mishra S; Gulyás M; Mahalakshmi P; Archunan G; Padmanabhan P; Gulyás B
    J Neurosci Methods; 2020 Feb; 331():108525. PubMed ID: 31756396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tomorrow today: organ-on-a-chip advances towards clinically relevant pharmaceutical and medical in vitro models.
    Rothbauer M; Rosser JM; Zirath H; Ertl P
    Curr Opin Biotechnol; 2019 Feb; 55():81-86. PubMed ID: 30189349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Organ-On-A-Chip Engineered Platform to Study the Microbiota-Gut-Brain Axis in Neurodegeneration.
    Raimondi MT; Albani D; Giordano C
    Trends Mol Med; 2019 Sep; 25(9):737-740. PubMed ID: 31422037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central Nervous System and its Disease Models on a Chip.
    Yi Y; Park J; Lim J; Lee CJ; Lee SH
    Trends Biotechnol; 2015 Dec; 33(12):762-776. PubMed ID: 26497426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organ-on-a-Chip: A New Paradigm for Drug Development.
    Ma C; Peng Y; Li H; Chen W
    Trends Pharmacol Sci; 2021 Feb; 42(2):119-133. PubMed ID: 33341248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adult human brain in preclinical drug development.
    Dragunow M
    Nat Rev Drug Discov; 2008 Aug; 7(8):659-66. PubMed ID: 18617887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development.
    Ronaldson-Bouchard K; Vunjak-Novakovic G
    Cell Stem Cell; 2018 Mar; 22(3):310-324. PubMed ID: 29499151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.
    Quigley EMM
    Curr Neurol Neurosci Rep; 2017 Oct; 17(12):94. PubMed ID: 29039142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Tumor Models on Chip and Integrated Microphysiological Analysis Platform (MAP) for Life Sciences and High-Throughput Drug Screening.
    Ngo H; Amartumur S; Tran VTA; Tran M; Diep YN; Cho H; Lee LP
    Biosensors (Basel); 2023 Feb; 13(2):. PubMed ID: 36831997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates.
    Cavero I; Guillon JM; Holzgrefe HH
    Expert Opin Drug Saf; 2019 Aug; 18(8):651-677. PubMed ID: 31268355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Gut-On-A-Chip Model for High Throughput Disease Modeling and Drug Discovery.
    Beaurivage C; Naumovska E; Chang YX; Elstak ED; Nicolas A; Wouters H; van Moolenbroek G; Lanz HL; Trietsch SJ; Joore J; Vulto P; Janssen RAJ; Erdmann KS; Stallen J; Kurek D
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The recent development and applications of fluidic channels by 3D printing.
    Zhou Y
    J Biomed Sci; 2017 Oct; 24(1):80. PubMed ID: 29047370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators.
    Ferreira DA; Rothbauer M; Conde JP; Ertl P; Oliveira C; Granja PL
    Adv Sci (Weinh); 2021 Apr; 8(8):2003273. PubMed ID: 33898174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human-Derived Organ-on-a-Chip for Personalized Drug Development.
    Jodat YA; Kang MG; Kiaee K; Kim GJ; Martinez AFH; Rosenkranz A; Bae H; Shin SR
    Curr Pharm Des; 2018; 24(45):5471-5486. PubMed ID: 30854951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.